← Eichor
Condition: End Stage Heart Failure Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: End Stage Heart Failure

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Roxadustat's Effect on Heart, Nutrition, and Inflammation in Hemodialysis Patients
Phase 1/Phase 2 · 1 location(s) · Mansoura University · NCT06903559Restrictive Fluid Management In Liver Transplantation (REFIL)
NA · 4 location(s) · Centre hospitalier de l'Université de Montréal (CHUM) · NCT07695363Validating Novel, Non-contrast Cardiac MRI Imaging in Haemodialysis Patients
Phase N/A · 1 location(s) · University of Leicester · NCT03586518Long-Term Survival After LVAD Implantation in End-Stage Heart Failure
Phase N/A · 1 location(s) · The Affiliated Nanjing Drum Tower Hospital of Nanjing Univer · NCT07382284Impella Reverse Remodeling in End-Stage Heart Failure
Phase N/A · 1 location(s) · Columbia University · NCT06800716Safety and Efficacy of Second Infusion of FAP iCDC in End-stage Dilated Cardiomyopathy
Phase 1 · 1 location(s) · Second Affiliated Hospital, School of Medicine, Zhejiang Uni · NCT07516288Noninvasive Cardiovascular Diagnosis of Patients With Fully Magnetically Levitated Blood Pumps
Phase N/A · 1 location(s) · Thomas Schlöglhofer, PhD, MSc · NCT04641416EMPAgliflozin in Heart Failure With PReserved Ejection Fraction and End Stage Renal Disease
Phase 4 · 2 location(s) · National Taiwan University Hospital · NCT06249945Staged Kidney Transplantation During Combined Heart/Kidney Transplantation
NA · 1 location(s) · Cedars-Sinai Medical Center · NCT06877169Comparing the Diagnostic Sensitivity and Specificity of Pleural Fluid N-Terminal Pro B-type Natriuretic Peptide (NT-proB
Phase N/A · 1 location(s) · Chinese University of Hong Kong · NCT05797649Empagliflozin in Heart Failure with Reduced Ejection Fraction and End Stage Renal Disease
Phase 4 · 2 location(s) · National Taiwan University Hospital · NCT06249932The Danish Warfarin-Dialysis Study - Safety and Efficacy of Warfarin in Patients With Atrial Fibrillation on Dialysis
Phase 4 · 13 location(s) · Nicholas Carlson · NCT03862859LVAD Versus GDMT in Ambulatory Advanced Heart Failure Patients
NA · 8 location(s) · Hospices Civils de Lyon · NCT04768322Cardio-Renal Registry
Phase N/A · 1 location(s) · Queen Mary University of London · NCT06521801The FILTRATE Trial: High-Rate Ultrafiltration for Intravascular Congestion
NA · 1 location(s) · Universidad Autonoma de Nuevo Leon · NCT07705269Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (
Phase 2/Phase 3 · 548 location(s) · CSL Behring · NCT05485961Sensor-based Congestion ALert for Events in Peritoneal Dialysis (SCALE-PD)
Phase N/A · 4 location(s) · Bodyport Inc. · NCT07059962Preventive Catheter Ablation for Ventricular arrhythmiaS in Patients With End-sTage Heart faiLure
NA · 1 location(s) · Heart and Diabetes Center North-Rhine Westfalia · NCT06556485Safety and Efficacy of Induced Pluripotent Stem Cell-derived Engineered Human Myocardium as Biological Ventricular Assis
Phase 1/Phase 2 · 3 location(s) · University Medical Center Goettingen · NCT04396899HIV+ Deceased Donor Heart Transplant Study for HIV+ Recipients
NA · 1 location(s) · University of Texas Southwestern Medical Center · NCT06659952Safety and Efficacy of FAP iCDC in End-stage Dilated Cardiomyopathy
Phase 1/Phase 2 · 1 location(s) · Second Affiliated Hospital, School of Medicine, Zhejiang Uni · NCT06902896
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.